Tizanidine
Vertebral Column Disorder
Stanford UniversitySmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 89/ 100
Competitive context
11 Active assets in the Vertebral Column Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Oxycodone Grünenthal GmbH | Phase 4 | BBB |
LIDOCAINE Medical College of Wisconsin | Phase 4 | BB |
DINITROGEN MONOXIDE Medical College of Wisconsin | Phase 4 | BB |
Glycopyrrolate Medical College of Wisconsin | Phase 4 | BB |
NEPENTHE MedtronicNeuro | Phase 4 | BB |
View all 39 →
Same molecule, other indications
Tizanidine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →